Skip to main content

CVD Risk Increased With Vasomotor Symptoms, History of Migraine

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 16, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, Feb. 16, 2024 -- Women with persistent vasomotor symptoms (VMS) and a history of migraine have an increased risk for cardiovascular disease (CVD), although the risk is attenuated with adjustment for CVD risk factors, according to a study published online Feb. 13 in Menopause.

Catherine Kim, M.D., M.P.H., from the University of Michigan in Ann Arbor, and colleagues conducted a secondary data analysis of 1,954 women in the Coronary Artery Risk Development in Young Adults study to examine whether VMS and migraine headaches are associated with the risk for CVD events and stroke.

The researchers identified 81 incident CVD events, including 42 strokes among 835 women with minimal VMS, 521 with increasing VMS, and 598 with persistent VMS. After adjustment for age, race, estrogen use, oophorectomy, and hysterectomy, women with histories of migraine and persistent VMS had a greater risk for CVD than those without migraine histories and with minimal/increasing VMS; these associations were attenuated and no longer significant after adjustment for CVD risk factors. Similarly, women with histories of migraine and persistent VMS had an increased stroke risk, which was also attenuated and no longer significant after adjustment for CVD risk factors.

"Our results should also be reassuring to women with either migraine history or persistent VMS over time, whose risk for CVD events in late middle-life does not appear to be significantly elevated," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted February 2024

Read this next

More Physical Activity Tied to Higher Odds of Hot Flashes

FRIDAY, May 31, 2024 -- Increases in physical activity increase the odds of menopause-related hot flashes, according to a study published online May 28 in Menopause. Sarah...

ASCO: Conjugated Equine Estrogen May Increase Risk for Ovarian Cancer

TUESDAY, May 28, 2024 -- Conjugated equine estrogen (CEE) taken alone for menopause may increase the risk for developing and dying from ovarian cancer, according to a study...

Fezolinetant Safe, Effective for Moderate-to-Severe Menopause Hot Flashes

MONDAY, May 20, 2024 -- Fezolinetant is safe and effective for moderate-to-severe vasomotor symptoms (VMS), according to a study presented at the annual European Congress of...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.